Sponsored by MI:RNA
The Continuum of Care Panel Discussion
Within our panel, we have expertise from Dr Andria Beal on epigenetics and accurate ageing of dogs, Dr Reiter on Anti-Ageing science, Professor Will Hendricks on cancer screening and early disease diagnosis using nucleotides and from Patrick Cooley on diet, exercise, new innovations and optimising wellness
Topics will include:
- Epigenetics & accurate age testing
- Anti-ageing science
- Early disease diagnosis
- Diet, exercise, and optimising wellness
Eve Hanks,
BVM&S CertAVP (EM) PhD MRCVS
Dr Eve Hanks is the CEO & Founder of MI:RNA. She has over 12 years of experience as a veterinary surgeon and is a though leader in microRNAs having studied, researched and published in this area for 9 years, with a particular interest in host interactions in response to immune system challenges. She is an innovator and entrepreneur and she used her clinical background for conception, development and implementation of MI:RNA’s pioneering technology.
Patrick Cooley,
MBA
Director of Create the New for Royal Canin US Veterinary Business - an internal startup creation and acceleration function
6 Years in the Pet Food industry with previous experience in snack foods (7 years), human medical (2 years), and Military (8 years)
Taylor Reiter,
MBA
Clinical Trials Research Veterinarian
Dog Aging Project, a team of veterinarians and scientists assembled with the goal of unlocking the secrets of aging.
Specific professional interests include chronic inflammation and cardiovascular disease
Veterinary medicine - 6 years
Colorado State College of Veterinary Medicine '23
Andria Beal,
Founder and CEO of EpiPaws- an epigenetic testing company for pets. We currently offer an age estimation test and will soon launch a new health monitoring test based on biological age. Our research is aimed at helping pet owners, veterinarians, and pet companies servicing the pet community to be more informed on current health status.
I have 15+ years research experience ranging from genetics to epigenetics working with mammals and fish.
Andria Beal,
MBA
Translational scientist driven to bring the precision medicine revolution to all populations
The Rise of Precision Medicine in Cats
Through her work in precision medicine and innovation, Eve is on the cutting edge of novel personalised care technologies. In this session, she will focus on the advantages and disadvantages of digital medicine, discuss the winners and the main stakeholders and how some of these innovations can be applied to practicing veterinary professionals.
This session will also take a look at future care, using clinical case studies, and introduce products that are being bought by owners at home. Finally, a deeper dive into diagnostics illustrates the proximity of this new technology and the way our roles in practice could change forever.
Eve Hanks,
BVM&S CertAVP (EM) PhD MRCVS
Dr Eve Hanks is the CEO & Founder of MI:RNA. She has over 12 years of experience as a veterinary surgeon and is a though leader in microRNAs having studied, researched and published in this area for 9 years, with a particular interest in host interactions in response to immune system challenges. She is an innovator and entrepreneur and she used her clinical background for conception, development and implementation of MI:RNA’s pioneering technology.
Get Your Certificates
Certificates are sent out at the end of each month
